Darbepoetin alfa is safe and effective for the treatment of renal anemia in diabetic and elderly dialysis patients.

被引：0
|
作者：
Martinez-Castelao, A [1 ]
Bestard, O [1 ]
机构：
[1] Bellvitge Hosp, Serv Nefrol Feixa Llarga, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [21] Effect of anemia treatment with epoetin alfa or darbepoetin alfa on left ventricular mass in patients with chronic kidney disease not on dialysis in Japan.
    Suzuki, Makoto
    Akaishi, Makoto
    Hada, Yoshiyuki
    Hiroe, Michiaki
    Aonuma, Kazutaka
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 67A - 67A
  • [22] Spotlight on Darbepoetin Alfa in the Treatment of Anemia in Patients with Cancer Receiving Chemotherapy
    M. Asif A. Siddiqui
    Gillian M. Keating
    BioDrugs, 2006, 20 : 321 - 323
  • [23] Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease
    Bradley A. Warady
    Mazen Y. Arar
    Gary Lerner
    Arline M. Nakanishi
    Catherine Stehman-Breen
    Pediatric Nephrology, 2006, 21 : 1144 - 1152
  • [24] Spotlight on darbepoetin alfa in the treatment of anemia in patients with cancer receiving chemotherapy
    Siddiqui, M. Asif A.
    Keating, Gillian M.
    BIODRUGS, 2006, 20 (05) : 321 - 323
  • [25] Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients
    Nissenson, AR
    Swan, SK
    Lindberg, JS
    Soroka, SD
    Beatey, R
    Wang, C
    Picarello, N
    McDermott-Vitak, A
    Maroni, BJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01) : 110 - 118
  • [26] Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease
    Warady, Bradley A.
    Arar, Mazen Y.
    Lerner, Gary
    Nakanishi, Arline M.
    Stehman-Breen, Catherine
    PEDIATRIC NEPHROLOGY, 2006, 21 (08) : 1144 - 1152
  • [27] Use of darbepoetin alfa for treatment of anemia associated with chronic kidney disease in pediatric bone marrow transplant patients.
    Barletta, GM
    Pietryga, D
    Abdel-Mageed, A
    Bunchman, TE
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 95 - 95
  • [28] Treatment of anemia with Aranesp® (darbepoetin-alfa) given once every two weeks in HIV seropositive patients.
    Tulpule, A
    Dharmapala, D
    Burian, P
    Espina, BM
    Jayne, G
    George, S
    Levine, AM
    BLOOD, 2004, 104 (11) : 849A - 849A
  • [29] Monthly darbepoetin-alfa administration in treating anemia in renal transplant recipients: Comparison with chronic kidney disease patients.
    Attallah, Nizar
    Frinak, Stan
    Karthikeyan, Vanji
    Faber, Mark
    Yee, Jerry
    Ramanathan, Sundar
    Venkat, K. K.
    Parasuraman, Ravi
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 360 - 360
  • [30] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Hattori, Motoshi
    Matsunaga, Akira
    Akioka, Yuko
    Fujinaga, Shuichiro
    Nagai, Takuhito
    Uemura, Osamu
    Nakakura, Hyogo
    Ashida, Akira
    Kamei, Koichi
    Ito, Shuichi
    Yamada, Takuji
    Goto, Yoshimitsu
    Ohta, Toshiyuki
    Hisano, Masataka
    Komatsu, Yasuhiro
    Itami, Noritomo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) : 582 - 588
12345